Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
Assessing the Potential Role of Anti-CD117 CAR T-Cells for Targeted Therapy in Advanced Systemic Mastocytosis
ASH 2021 Systemic Mastocytosis Wrap-Up
Conference Correspondent
CAR T-cell immunotherapy is highly efficient because of its ability to target specific tumor antigens. Preliminary evidence suggests that CAR T-cells directed against CD117, the KIT receptor, may emerge as a therapeutic option for advanced systemic mastocytosis.
Read More
Whole Genome Sequencing Detects Chromosomal Aberrations Associated with Systemic Mastocytosis
ASH 2021 Systemic Mastocytosis Wrap-Up
Conference Correspondent
Cytogenetic aberrations are rarely found by cytogenetics in systemic mastocytosis but are associated with advanced disease. Whole genome sequencing detects both chromosomal aberrations and non-
KIT
gene mutations and can be used as an alternative to cytogenetics for assessing disease risk.
Read More
Navigation Is About Value
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), said she attended the AVBCC Summit because oncology nurse and patient navigation is "all about value" across the cancer care continuum.
Read More
Navigators Need a Place at the Table
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
We are making progress, but oncology nurse navigators need to have a louder voice in these meetings with stakeholders because, as patient advocates, they are often the keepers of patient experience, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+).
Read More
Bringing the Patient Voice to Stakeholders
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), said navigators have "boots on the ground" experiences with patients with cancer, their families, and their caregivers, and oncology navigators are the professionals best suited to deliver these voices to the stakeholders who need to hear them.
Read More
A Navigator for Every Patient
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
Every patient with cancer should have a navigator, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), and she would like to see AVBCC take a role in realizing this vision.
Read More
Navigators Have Lessons to Share
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+), would like to see everyone with an interest in patient care come to the next AVBCC Summit and learn from navigators how to sustain navigation programs and to learn more about financial navigation.
Read More
Navigators Gather as Unified Presence
By
Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Videos
Oncology navigators should attend because the AVBCC Summit provides an opporutnity to come together as one unified voice and also to hear from others in the field, said Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN, Program Director, Academy of Oncology Nurse & Patient Navigators (AONN+).
Read More
AVBCC Summit Best Conference to Address Questions About Value-Based Care
By
Sibel Blau, MD
Videos
Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties, said her organization is interested in practice transformation and value-based care and AVBCC is the "best conference ever" to meet the individuals who can address questions about value-based care.
Read More
Priceless Networking at AVBCC Summit
By
Sibel Blau, MD
Videos
Understanding how other institutions, practices, and companies are envisioning the future of value-based care is an invaluable benefit, and the chance to network with others is "priceless," said Sibel Blau, MD, President & CEO, Quality Cancer Care Alliance Network, Medical Director, Oncology Division, Northwest Medical Specialties.
Read More
Page 31 of 329
28
29
30
31
32
33
34
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
3.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma